Discover the top affordable school supplies for 2026. Find the best overall, value picks, and more to save on back-to-school essentials.
The Latest
6 Best Discount School Supplies in 2026
Piero Cipollone: From Vision To Delivery: Building Europe’s Tokenised Financial Market
ECB’s Piero Cipollone discusses the transition from concept to implementation in building Europe’s tokenised financial infrastructure.
AI Management Skills Tested in Live Business Crisis Simulation — Not Just Chat Quality
A live AI management simulation reveals that the true test isn’t how well models chat but how they handle crises, honesty, and decision-making under pressure—crucial for business success.
How to Set Up Amazon Price Alerts With External Tools
Optimize your Amazon shopping with external tools—learn how to set up price alerts and never miss a deal again.
Delay To The November 2026 RTGS Standards Release
The Bank of England has announced a delay in the release of the revised RTGS standards, now scheduled for November 2027, citing implementation challenges.
Sigenergy Delivers Strong H1 2026 Performance As AI-Driven Energy Innovation Powers Global Growth
Sigenergy’s H1 2026 results show significant growth, fueled by AI-driven energy solutions, highlighting its expanding global influence and technological leadership.
California Baptist University, Riverside County Launch ANCHOR Fellowship To Develop Future Human Services Leaders
California Baptist University and Riverside County have announced the launch of the ANCHOR Fellowship to develop future leaders in human services.
HUTCHMED Announces NMPA Approval For ATLED® (Fanregratinib) For The Treatment Of Patients With FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma
HUTCHMED announces NMPA approval for ATLED® (Fanregratinib) for intrahepatic cholangiocarcinoma with FGFR2 fusion/rearrangement, expanding treatment options.
Meeting Of 22-23 July 2026
The European Central Bank convened on July 22-23, 2026, to discuss monetary policy amid ongoing economic uncertainties. Key decisions are expected soon.
Jazz Pharmaceuticals Announces Pricing Of Upsized Private Offering Of $1.1 Billion Of 1.875% Exchangeable Senior Notes Due 2032 And Concurrent Ordinary Share Repurchases
Jazz Pharmaceuticals has announced the pricing of an upsized $1.1 billion private offering of exchangeable senior notes due 2032, alongside share repurchase plans.
